CD BioGlyco has developed chemical synthesis methods and enzyme synthesis methods to provide our customers with high-quality customized sialyl Lewis x antigen and its derivatives production services. We are confident to be your scientific assistant in the field of glycobiology.
What is Sialyl Lewis x Antigen?
Typical tumor-associated carbohydrate antigens are two carbohydrate structures named sialyl Lewis a and sialyl Lewis x. Sialyl Lewis x, a member of body carbohydrate, is an inherent blood-type tetrasaccharide on the surface of different cells, the lymphocyte, neutrophil, some T cells, multiple tumor cells and so on. Sialyl Lewis x is the most important ligand of the three selectins, L-selectin, E-selectin, and P-selectin, and plays important role in multiple physiological phenomena by interacting with selectins. For example, the expression of sialyl Lewis x on leukocytes contributes to their function in the inflammatory response via interaction with E-selectin expressed on endothelial cells. Sialyl Lewis x is involved in the recruitment of leukocytes to lymphoid tissues and inflammation sites.
The biosynthesis of sialylated Lewis antigens (sialyl Lewis a and sialyl Lewis x) requires first the α2,3-sialylation of Gal prior toα-1,3/4-fucosylation. ST3Gal IV and ST3Gal VI mainly act on type 2 disaccharides, leading to the biosynthesis of sialyl Lewis x. For the subsequent fucosylation, FucT VII shows a restricted substrate-specific city since it forms only sialyl Lewis x.
Fig.1 Structure of sialyl Lewis x antigen. (Wikipedia)
Our Services
CD BioGlyco offers high-quality sialyl Lewis a synthesis and analysis service according to customers' research needs. Our services include but are not limited to:
Chemical synthesis of sialyl Lewis x and its derivatives. For example, we synthesize several sialyl Lewis x glycoconjugates including sialyl dimeric Lewis x, fluorescent sialyl Lewis x glycosphingolipids, sialyl trimeric Lewis x, sialyl Lewis x glycosphingolipids. And these compounds will be coupled with protein and then be used to conduct further preclinical studies for the diagnosis of cancer.
We also provide sialyl Lewis x synthesis by enzymatic synthesis strategy, which employs enzyme nucleotide donor recycling. Glycosyltransferases have become valuable tools for regio- and stereoselective glycosylations. Sialyl Lewis x is prepared by using β1,4-galactosyltransferase (GalT) to form Galβ1,4GlcNAc, recombinant α-2,3-sialyltransferase (SiaT) to form NeuAcα2,3Galβ1,4GlcNAc, and α-1,3-fucosyltransferase(FucT) to form NeuAcα2,3Galβ1,4(Fucα1,3)GlcNAc. This three-enzyme system has been utilized extensively later on in the synthesis of sialyl Lewis x.
Chemoenzymatic synthesis of O-sulfated sialyl Lewis x antigens containing different sialic acid forms and O-sulfation at different locations using one-pot multienzyme (OPME) sialylation systems. O-Sulfated sialyl Lewis x structures play important roles in immune regulation, inflammation, and cancer metastasis.
Structural analysis of sialyl Lewis x using 2D NMR
Advantages of Us
Optimized synthesis service of sialyl Lewis x and its derivatives
Customized solutions
A combination of multiple synthesis techniques
Efficient and reliable
CD BioGlyco is one of the most reliable partners equipped with experienced scientists. We are committed to providing you with reliable products of sialyl Lewis x antigen. If you are interested in our services, please contact us for more details.
References
Ugorski, M.; Laskowska, A. Sialyl Lewis (a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells. Acta Biochimica Polonica. 2002, 49(2): 303-311.
Pudelko, M.; et al. Chemical and chemoenzymatic synthesis of glycopeptide selectin ligands containing sialyl Lewis X structures. ChemBioChem. 2010, 11(7): 904-930.
This service is for Research Use Only, not intended for any clinical use.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.